ECHOCARDIOGRAPHIC AND LABORATORY MARKERS OF CHRONIC HEART FAILURE: WHETHER IT IS POSSIBLE TO USE THEM IN RHEUMATIC MITRAL DISEASES?

QR Code

ECHOCARDIOGRAPHIC AND LABORATORY MARKERS OF CHRONIC HEART FAILURE: WHETHER IT IS POSSIBLE TO USE THEM IN RHEUMATIC MITRAL DISEASES?

Aim. To find echocardiographic indicators of heart remodelling that improve estimation of heart failure (HF) severity. To evaluate sensitivity of laboratory markers of HF, brain (BNP) and atrial (ANP) natriuretic peptides, in patients with mitral heart diseases of rheumatic aetiology.Material and me...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. A. Kazakovtseva, N. A. Shostak
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	mitral disease heart remodelling brain natriuretic peptide
Online Access:	https://www.rpcardio.online/jour/article/view/593
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

MITRAL ANNULAR CALCIFICATION IN ELDERLY PATIENTS. CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS
by: N. S. Chipigina, et al.
Published: (2016-01-01)

TISSUE DOPPLEROGRAPHY IN EARLY DIAGNOSIS OF FUNCTIONAL MYOCARDIAL DISORDERS IN ARTERIAL HYPERTENSION
by: Y. A. Vasyuk, et al.
Published: (2016-01-01)

EFFECTIVENESS OF PHARMACOTHERAPY FOR NORMALIZATION OF THE BRAIN NATRIURETIC PEPTIDE, RENINE-ANGIOTENSINALDOSTERONE SYSTEM ACTIVATION AFTER SURGICAL REVASCULARIZATION OF MYOCARDIUM IN POSTINFARCTION CARDIOSCLEROSIS PATIENTS
by: S. A. Kovalev, et al.
Published: (2016-12-01)

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases
by: A. Ya. Panarina, et al.
Published: (2024-11-01)

Features of cardiovascular remodeling, the level of neurohumoral factors depending on the degree of chronic heart failure and kidney dysfunction
by: U. K. Kamilova, et al.
Published: (2019-06-01)

CLINICAL IMPORTANCE OF IDIOPATHIC MITRAL ANNULAR CALCIFICATION
by: N. S. Chipigina, et al.
Published: (2016-01-01)

Endothelium-derived C-type natriuretic peptide offsets the pathogenesis of pulmonary hypertension
by: Joshua P. Dignam, et al.
Published: (2025-09-01)

The level of Brain natriuretic Peptide as a Predictor of the Postoperative Period at Operations with Artificial Blood circulation
by: Yu. A. Bakhareva, et al.
Published: (2019-01-01)

Enalapril in patients after mitral valve replacement
by: O. L. Barbarash, et al.
Published: (2007-08-01)

GENDER AND AGE DIFFERENCES OF BRAIN NATRIURETIC PEPTIDE CONCENTRATION IN PATIENTS WITH MYOCARDIAL INFARCTION
by: E. N. Usoltseva, et al.
Published: (2014-07-01)

Efficiency of meldonium application in complex treatment of patients with chronic heart failure decompensation
by: A. S. Sycheva, et al.
Published: (2021-06-01)

Left ventricular remodelling early after surgical correction of mitral regurgitation: stroke volume maintenance
by: E. A. Ashikhmina, et al.
Published: (2013-02-01)

Dapagliflozin effect on functional mitral regurgitation and myocardial remodelling: The DEFORM trial
by: Zhuoshan Huang, et al.
Published: (2025-08-01)

Point-of-care N-terminal pro-brain natriuretic peptide testing in patients with heart failure: data from the DREAM study
by: F. I. Belyalov, et al.
Published: (2024-06-01)

NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL
by: A. S. Galjavich, et al.
Published: (2016-01-01)

Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hypertension of various etiology
by: Yu. A. Andreeva, et al.
Published: (2008-12-01)

Brain natriuretic peptide and all-cause mortality in patients treated with haemodialysis
by: Maria K Svensson, et al.
Published: (2025-06-01)

Impact of acute covid-19 on cardiac function in the long term: a systematic review
by: Luiz Humberto Marochi, et al.
Published: (2025-07-01)

PROGNOSTIC ROLE OF CHRONIC HEART FAILURE SEVERITY MARKERS AND RISK STRATIFICATION IN PATIENTS AGED 75 YEARS OR OLDER: BNUP-AGE SURVIVAL MODEL (NEVA-75)
by: M. Yu. Sitnikova, et al.
Published: (2010-10-01)

Novel and conventional echocardiographic parameters for choosing management tactics in patients with degenerative mitral valve diseases
by: O. V. Tereshina, et al.
Published: (2022-09-01)

Differential beta-adrenoblocker therapy in chronic heart failure: the role of age, gender, and co-morbidity
by: S. N. Tereshchenko, et al.
Published: (2009-10-01)

Tissue myocardial Doppler echocardiography in the assessment of right ventricular function among patients with pulmonary hypertension of various aetiology
by: Yu. A. Andreeva, et al.
Published: (2010-04-01)

BRAIN NATRIURETIC PEPTIDE AS BIOCHEMICAL MARKER FOR STRUCTURAL AND FUNCTIONAL HEART DISORDERS IN ARTERIAL HYPERTENSION
by: S. V. Ivanova, et al.
Published: (2015-12-01)

The relationship of gene polymorphism with the heart failure risk in patients with hypertension and high adherence to treatment
by: N. A. Koziolova, et al.
Published: (2020-04-01)

Associations of elevated levels of brain natriuretic peptide and heart failure and their contribution to survival in the Russian middle-aged population: data from the ESSE-RF study
by: S. A. Shalnova, et al.
Published: (2023-07-01)

INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES
by: S. R. Gilyarevskiy, et al.
Published: (2017-12-01)

DIAGNOSTIC SIGNIFICANCE OF NOVEL MARKERS FOR ASSESSMENT OF MYOCARDIUM CONDITION IN OBSTRUCTIVE DIFFUSE-GENERALIZED FORM OF HYPERTROPHIC CARDIOMYOPATHY
by: Yu. V. Frolova, et al.
Published: (2016-11-01)

Modification of the Association of B-Type Natriuretic Peptides With Mortality and Hospitalization Outcomes by Sex
by: David Bobrowski, MD, et al.
Published: (2025-08-01)

Hemodynamic maladaptation of a pregnant woman as an early marker of preeclampsia
by: E. V. Timokhina, et al.
Published: (2023-09-01)

Heart remodelling type role and effectiveness of lisinopril and bisoprolol therapy among patients with rheumatic mitral disease
by: T. A. Abdullaev, et al.
Published: (1970-01-01)

The Link Between Left Atrial Longitudinal Reservoir Strain and Mitral Annulus Geometry in Patients with Dilated Cardiomyopathy
by: Despina-Manuela Toader, et al.
Published: (2025-07-01)

DIAGNOSTICS AND TREATMENT OF MITRAL VALVE PROLAPSE
by: D. A. Kuzhel, et al.
Published: (2016-01-01)

Left ventricular remodelling and diastolic dysfunction in mitral valve prolapse
by: E. G. Malev, et al.
Published: (2013-04-01)

Impact of Surgical Ablation of Atrial Fibrillation on the Progression of Tricuspid Regurgitation and Right‐Sided Heart Remodeling After Mitral‐Valve Surgery: A Propensity‐Score Matching Analysis
by: Jiangang Wang, et al.
Published: (2016-12-01)

Relationship between epicardial/visceral obesity and features of myocardial remodeling in patients with acquired mitral valve disease
by: E. V. Dren', et al.
Published: (2025-03-01)

Evaluation of proinflammatory cytokines and brain natriuretic peptide in patients with rheumatic heart diseases and coronary heart disease complicated by chronic heart insufficiency
by: N A Shoslak, et al.
Published: (2005-04-01)

¿Existe todavía un lugar para la cirugía valvular mitral aislada en la insuficiencia mitral funcional? Un panorma actual
by: Ovidio A. García-Villarreal
Published: (2025-07-01)

Transcatheter mitral valve edge-to-edge repair in patients with severe mitral regurgitation: data from the MitraClip Russia Trial
by: T. E. Imaev, et al.
Published: (2022-03-01)

B-type natriuretic peptide informativeness in myocardial revascularization with cardio-pulmonary bypass
by: I. A. Kozlov, et al.
Published: (2024-08-01)

Assessment of glomerular and tubulointerstitial apparatus state depending on the level of the natriuretic peptide in hypertension patients
by: A. I. Chernyavina
Published: (2020-04-01)